Paper39403134
Hyaluronic acid-solid lipid nano transporter serum preparation for enhancing topical tretinoin delivery: skin safety study and visual assessment of skin.
Mehmood Y and 7 others. Front Pharmacol, 2024. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Hyaluronic acid-solid lipid nano transporter serum preparation for enhancing topical tretinoin delivery: skin safety study and visual assessment of skin. Papers, record 39403134. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39403134
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Hyaluronic acid-solid lipid nano transporter serum preparation for enhancing topical tretinoin delivery: skin safety study and visual assessment of skin.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References30
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16784513 | Hyaluronic acid fillers. | Dermatol Ther | 2006 | https://conductscience.org/library/papers/16784513 | PubMed |
| 2 | 31969986 | Emerging role of nanosuspensions in drug delivery systems. | Biomater Res | 2020 | https://conductscience.org/library/papers/31969986 | PubMed |
| 3 | 12460720 | Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. | Adv Drug Deliv Rev | 2002 | https://conductscience.org/library/papers/12460720 | PubMed |
| 4 | 33322246 | Retinoic Acid and Its Derivatives in Skin. | Cells | 2020 | https://conductscience.org/library/papers/33322246 | PubMed |
| 5 | 34345586 | Wrinkle reduction using a Sasang constitutional medicine-based topical herbal cream in So-eum subjects: A split-face randomized double-blind placebo-controlled study. | Integr Med Res | 2022 | https://conductscience.org/library/papers/34345586 | PubMed |
| 6 | 29441672 | Role of solid lipid nanoparticles as photoprotective agents in cosmetics. | J Cosmet Dermatol | 2019 | https://conductscience.org/library/papers/29441672 | PubMed |
| 7 | 29532749 | Nanotechnological Advances for Cutaneous Release of Tretinoin: An Approach to Minimize Side Effects and Improve Therapeutic Efficacy. | Curr Med Chem | 2018 | https://conductscience.org/library/papers/29532749 | PubMed |
| 8 | 20373062 | DDSolver: an add-in program for modeling and comparison of drug dissolution profiles. | AAPS J | 2010 | https://conductscience.org/library/papers/20373062 | PubMed |
| 9 | 26969582 | Topical Retinoids: Therapeutic Mechanisms in the Treatment of Photodamaged Skin. | Am J Clin Dermatol | 2016 | https://conductscience.org/library/papers/26969582 | PubMed |
| 10 | 37504430 | Amikacin-Loaded Chitosan Hydrogel Film Cross-Linked with Folic Acid for Wound Healing Application. | Gels | 2023 | https://conductscience.org/library/papers/37504430 | PubMed |
| 11 | 28558147 | Safety and efficacy of a bioabsorbable fluticasone propionate-eluting sinus dressing in postoperative management of endoscopic sinus surgery: a randomized clinical trial. | Int Forum Allergy Rhinol | 2017 | https://conductscience.org/library/papers/28558147 | PubMed |
| 12 | 24939745 | Advances in lipid-based colloid systems as drug carrier for topic delivery. | J Control Release | 2014 | https://conductscience.org/library/papers/24939745 | PubMed |
| 13 | 17544165 | Lipid nanoparticles for improved topical application of drugs for skin diseases. | Adv Drug Deliv Rev | 2007 | https://conductscience.org/library/papers/17544165 | PubMed |
| 14 | 16011893 | Characterisation of surface-modified solid lipid nanoparticles (SLN): influence of lecithin and nonionic emulsifier. | Eur J Pharm Biopharm | 2005 | https://conductscience.org/library/papers/16011893 | PubMed |
| 15 | 32231052 | In-Vitro and In-Vivo Evaluation of Velpatasvir- Loaded Mesoporous Silica Scaffolds. A Prospective Carrier for Drug Bioavailability Enhancement. | Pharmaceutics | 2020 | https://conductscience.org/library/papers/32231052 | PubMed |
| 16 | 19452677 | Susceptibility of Candida albicans and Enterococcus faecalis to Chitosan, Chlorhexidine gluconate and their combination in vitro. | Aust Endod J | 2009 | https://conductscience.org/library/papers/19452677 | PubMed |
| 17 | 37998961 | Microsponge-Based Gel Loaded with Immunosuppressant as a Simple and Valuable Strategy for Psoriasis Therapy: Determination of Pro-Inflammatory Response through Cytokine IL-2 mRNA Expression. | Gels | 2023 | https://conductscience.org/library/papers/37998961 | PubMed |
| 18 | 19422381 | Characterization of ZK 245186, a novel, selective glucocorticoid receptor agonist for the topical treatment of inflammatory skin diseases. | Br J Pharmacol | 2009 | https://conductscience.org/library/papers/19422381 | PubMed |
| 19 | 31680076 | Facile synthesis of mesoporous silica nanoparticles using modified sol-gel method: Optimization and in vitro cytotoxicity studies. | Pak J Pharm Sci | 2019 | https://conductscience.org/library/papers/31680076 | PubMed |
| 20 | 20217528 | Lipid nanoparticles: effect on bioavailability and pharmacokinetic changes. | Handb Exp Pharmacol | 2010 | https://conductscience.org/library/papers/20217528 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39403134
GET https://conductscience.org/api/papers/v1/39403134/references?page=2